AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Iron Sucrose Injection USP
5 registrations across 3 African markets— 5 active
Markets with Iron Sucrose Injection USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Akurose Injection | 🇿🇲Zambia | UNOSOURCE PHARMA LTD | active | Sept 2030 |
| FERABEST Solution For Injection | 🇰🇪Kenya | Vitacura Pharmaceuticals | active | Jul 2030 |
| Agifer injection 20mg/ml Injection | 🇰🇪Kenya | Agio Pharmaceticals Limited | active | Apr 2030 |
| AKUROSE Injection | 🇷🇼Rwanda | AKUMS DRUGS & PHARMACEUTICALS LTD | active | Jan 2030 |
| Zenfer injection 20mg/ml Injection | 🇰🇪Kenya | SAI PHARMACEUTICALS LIMITED | active | Mar 2027 |
Iron Sucrose Injection USP in Africa — Regulatory Overview
Iron Sucrose Injection USP is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Rwanda, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 5 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.